2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
The 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting took place from June 24 to June 27 in Chicago, Illinois. The SNMMI conference provides an overview of the latest research on nuclear medicine and molecular imaging, as well updates on new developments and practical applications.
Advertisement
Advertisement
The primary endpoint of dCR at six months strongly favored 131I-apamistamab with 22% dCR versus 0% for conventional care.
Multiple regression did not define any independent predictor of response for early evaluation among the baseline parameters.